This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Plaintiffs move for dismissal of Jazz defendants from US Xyrem antitrust case

( September 30, 2025, 20:49 GMT | Official Statement) -- MLex Summary: Plaintiffs Humana, Molina Healthcare, Blue Cross Blue Shield and others moved for dismissal of defendant Jazz Pharmaceuticals from their US antitrust claims over the drug Xyrem pursuant to settlement agreements between the parties. "Plaintiffs have executed settlement agreements that resolved their respective claims against Jazz. Plaintiffs thus seek dismissal of Jazz from their respective cases — and the claims they each raised against Jazz therein — with prejudice," said the plaintiffs' motion to dismiss, filed to the Northern District of California.See attached document....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections